These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 9115584)

  • 1. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
    Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in cell cycle regulation in mouse skin tumors.
    Balasubramanian S; Ahmad N; Jeedigunta S; Mukhtar H
    Biochem Biophys Res Commun; 1998 Feb; 243(3):744-8. PubMed ID: 9500999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis.
    Rojas P; Cadenas MB; Lin PC; Benavides F; Conti CJ; Rodriguez-Puebla ML
    Oncogene; 2007 Mar; 26(12):1723-30. PubMed ID: 16983339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
    Al-Aynati MM; Radulovich N; Ho J; Tsao MS
    Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII.
    Go C; He W; Zhong L; Li P; Huang J; Brinkley BR; Wang XJ
    Oncogene; 2000 Jul; 19(32):3623-31. PubMed ID: 10951568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cyclin D1 in mouse skin carcinogenesis.
    Bianchi AB; Fischer SM; Robles AI; Rinchik EM; Conti CJ
    Oncogene; 1993 May; 8(5):1127-33. PubMed ID: 8479737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
    Geum D; Sun W; Paik SK; Lee CC; Kim K
    Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
    Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
    Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse.
    Balasubramanian S; Kim KH; Ahmad N; Mukhtar H
    Oncogene; 1999 Feb; 18(6):1297-302. PubMed ID: 10022811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclins and cdks throughout murine carcinogenesis.
    Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P
    Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
    Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
    Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
    Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
    Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
    Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-type cyclins and G1 progression during liver development in the rat.
    Boylan JM; Gruppuso PA
    Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
    Bartkova J; Lukas J; Müller H; Strauss M; Gusterson B; Bartek J
    Cancer Res; 1995 Feb; 55(4):949-56. PubMed ID: 7850812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of G1 cell cycle markers and the effect of adenovirus-mediated overexpression of p21Waf-1 in squamous cell carcinoma of the esophagus.
    Fujii T; Kato S; Yamana H; Tanaka Y; Fujita H; Shirouzu K; Morimatsu M
    Int J Oncol; 2001 Jan; 18(1):157-63. PubMed ID: 11115554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
    Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
    Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication.
    Gong J; Traganos F; Darzynkiewicz Z
    Cell Growth Differ; 1995 Nov; 6(11):1485-93. PubMed ID: 8562487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.